EZH2 and neoplasm: Treatment of H460 tumor xenografts with GO-203/NPs32 resulted in marked downregulation of EZH2 (Fig. 2F, left and right), supporting the premise that targeting the MUC1-C cytoplasmic domain in vitro and in vivo is sufficient for suppression of EZH2 expression.